L582-0295 Screening compound: N-BUTYL-1-[3-(4-METHYLBENZENESULFONAMIDO)BENZOYL]PIPERIDINE-4-CARBOXAMIDE

L582-0295 Screening compound: N-BUTYL-1-[3-(4-METHYLBENZENESULFONAMIDO)BENZOYL]PIPERIDINE-4-CARBOXAMIDE
L582-0295 Screening compound: N-BUTYL-1-[3-(4-METHYLBENZENESULFONAMIDO)BENZOYL]PIPERIDINE-4-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L582-0295
N-BUTYL-1-[3-(4-METHYLBENZENESULFONAMIDO)BENZOYL]PIPERIDINE-4-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L582-0295

Molecular Formula

C24H31N3O4S (C24 H31 N3 O4 S)

Compound Name

N-BUTYL-1-[3-(4-METHYLBENZENESULFONAMIDO)BENZOYL]PIPERIDINE-4-CARBOXAMIDE

IUPAC name

N-butyl-1-[3-(4-methylbenzenesulfonamido)benzoyl]piperidine-4-carboxamide

SMILES

CCCCNC(C(CC1)CCN1C(c1cccc(NS(c2ccc(C)cc2)(=O)=O)c1)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.542

Distribution Coefficient, logD

3.534

Water Solubility, LogSw

-3.58

Polar Surface Area

82.063

Acid Dissociation Constant (pKa)

9.15

Base Dissociation Constant (pKb)

1.01

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

L582-0295 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L582-0295 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L582-0295?
Check Price and Availability of L582-0295, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L582-0295 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L582-0295
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L582-0295
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L582-0295 available by request